Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.

Inclusion Criteria:

• Macular edema
• Received at least 2 OZURDEX® injections

Exclusion Criteria:

• Received OZURDEX® injections as part of a clinical study